West Pharmaceutical Servs Q4 Adjusted EPS $1.83 Beats $1.78 Estimate, Sales $732.00M Miss $739.47M Estimate

Author: Benzinga Newsdesk | February 15, 2024 07:02am
West Pharmaceutical Servs (NYSE:WST) reported quarterly earnings of $1.83 per share which beat the analyst consensus estimate of $1.78 by 2.81 percent. This is a 3.39 percent increase over earnings of $1.77 per share from the same period last year. The company reported quarterly sales of $732.00 million which missed the analyst consensus estimate of $739.47 million by 1.01 percent. This is a 3.29 percent increase over sales of $708.70 million the same period last year.

Posted In: WST